morris avenue housing development fund company, inc.

885second avenue
31st floor
new york, new york 10017

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 21, 2014

NYS DOS ID#
4580586

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2014 - MORRIS AVENUE HOUSING DEVELOPMENT FUND COMPANY, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Neighborhoods That Play Hard to Get
    By STEFANOS CHEN - Friday Aug 11, 2017

    In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.

    Source: NYT > Home Page
  • Inside New York City’s Priciest Rentals
    By CAROLINE BIGGS - Friday Sep 1, 2017

    Some New Yorkers could afford to buy multimillion-dollar properties, but they’d rather rent a place for upward of $20,000 a month.

    Source: NYT > Home Page
  • Activist investor turns up heat on owner of Saks Fifth Avenue
    By Lisa Fickenscher - Monday Jul 31, 2017

    An activist investor is turning up the heat on Saks Fifth Avenue owner Hudson’s Bay Co. Hedge fund Land and Buildings fired off its second letter in six weeks to the board of Hudson’s Bay on Monday, threatening to remove board members if the department store company doesn’t sell some of its prized real estate....

    Source: New York Post: Business
  • New Development: Soft in the Middle, Splashy Up Top
    By STEFANOS CHEN - Friday Sep 15, 2017

    The luxury market in New York is pulling in two directions, with developers betting on big-ticket palatial aeries and million-dollar “starter” homes.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • NY AG presses TransUnion, Experian for cybersecurity details
    By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017

    ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.

    Source: SFGATE.com: Tech News